Regulatory Issues

X-Waiver No Longer Required to Treat Opioid Use Disorder

In DEA guidance released in Jan 2023, an X-Waiver is no longer required to treat patients with buprenorphine for opioid use disorder. ACEP has more details about treatment options and training requir...

Advocacy Win: Deductibles Added to Insurance Cards

Impacted by EM Consolidation? ACEP Tells the Feds

Workforce Advocacy

January 2022 Board Blog - Future Plans, Challenging an Unbalanced Law, and More

State Legislative/Regulatory Committee

Capital (30) Minutes

Other Federal Updates and Guidance

State Waiver of Liability

EMTALA

Leadership & Advocacy Conference

Emergency Medicine Alternative Payment Models: Frequently Asked Questions

Advocating Against 2021 Medicare Cuts

Acute Unscheduled Care Model

ACEP4U: Federal Surprise Billing (Out-of-Network Billing) Advocacy

ACEP4U: Electronic Health Records (EHR)

Medicare Reimbursement for Emergency Physicians

ACEP4U: Drug Shortages

Health Care Reform Letters to Congress and Regulatory Agencies

Congress Approves Comprehensive Addiction and Recovery Act

ACEP-Supported Innovations Bill Sent to President

Physician Reimbursement

Medicare, Medicaid & CHIP

Health Care Reform